SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K



                             Current Report Pursuant
                          to Section 13 or 15(d) of the
                       Securities and Exchange Act of 1934



        Date of report (Date of earliest event reported) October 10, 1997
                                                        ------------------------



                                OrthoLogic Corp.
- --------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in Its Charter)



                                    Delaware
- --------------------------------------------------------------------------------
                 (State or Other Jurisdiction of Incorporation)



            0-21214                                        86-0585310
- -------------------------------             ------------------------------------
   (Commission File Number)                 (I.R.S. Employer Identification No.)



  2850 South 36th Street, Phoenix, Arizona                          85034
- --------------------------------------------------------------------------------
  (Address of Principal Executive Offices)                        (Zip Code)



                                 (602) 437-5520
- --------------------------------------------------------------------------------
              (Registrant's Telephone Number, Including Area Code)

Item 5. Other Events.

On October 10, 1997,  OrthoLogic  Corp.  announced the  appointment of Thomas R.
Trotter,  49, to the position of president  and CEO. He will join the company on
October 20 and will be appointed a member of the Board of Directors.

Trotter,  formerly  president,   critical  care  division,  of  St.  Louis-based
Mallinckrodt,  Inc., brings a 20-year career in the  medical-device  industry to
OrthoLogic, as well as extensive expertise in sales and marketing.

"With this  announcement,  OrthoLogic  reinforces  its  corporate  philosophy of
focusing on innovation,  integrity and initiative," said Dr. Allan M. Weinstein,
OrthoLogic's  founder and former  chairman and CEO,  who last month  assumed the
title of vice chairman. "Tom is an extremely capable, action-oriented individual
with an  outstanding  record of success in various size  companies  ranging from
venture start-ups to billion-dollar multinationals. In handing over the reins to
Tom Trotter,  I'm confident he is the man to take us to the next level of growth
and profitability."

John  M.  Holliman  III,  OrthoLogic's  chairman  and a  founding  institutional
investor, added, "We couldn't be more delighted that Tom has joined us. We fully
expect that Tom's  leadership  will enable us to continue  bringing  innovative,
quality  products  to market,  reinforce  our  existing  product  line,  and add
sustained value for our shareholders."

Prior to his most  recent  post,  Trotter  held  various  other  positions  with
Mallinckrodt,   including  senior  vice  president,  U.S.  markets;  group  vice
president,  anesthesiology  and critical care  division;  and vice president and
general manager,  critical care division.  Before joining  Mallinckrodt in 1988,
Trotter was president and CEO of Diamond Sensor Systems, a successful Ann Arbor,
Mich.-based  venture start-up and held senior general management  positions with
Shiley, Inc., Irvine, Calif., then a division of Pfizer, Inc.

"I look forward to leading  OrthoLogic  into a new era of growth," said Trotter.
"As a key part of my initial charter,  I plan to focus on sales and marketing to
accelerate  the growth of innovative  products in continuous  passive motion and
bone-growth  stimulation as well as build sales of exciting new products such as
Hyalgan."

Trotter  replaces Dr. Frank Magee,  who served as acting  president  and oversaw
day-to-day  operations of the company during the recruitment  process. Dr. Magee
will  assume the  position of  executive  vice  president.  Dr.  Weinstein  will
continue to focus his activities exclusively on strategic business opportunities
and will remain a member of the Board of Directors.

OrthoLogic,  founded in 1987,  develops,  manufactures  and markets  proprietary
technologically  advanced  orthopedic devices designed to promote the healing of
musculoskeletal tissue.

The statements in this report regarding  growth,  sales and profitability of the
company  are  forward-looking  statements,  which are made  pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995. These
forward-looking  statements  involve  risks and  uncertainties  that could cause
actual results to differ  materially.  Factors that could cause or contribute to
such  differences   include,   but  are  not  limited  to,  the  acceptance  and
effectiveness  of new management,  potential costs and delays in integrating the
direct sales force, potential costs and delays in integrating acquisitions,  and
the  company's  dependence  for sales on approval  by  third-party  payers.  The
forward-looking  statements  should be  considered  in light of these  risks and
uncertainties.
                                        2

                                   SIGNATURES

                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                                   ORTHOLOGIC CORP.
                                   (Registrant)


October 10, 1997                   By /s/ Allen R. Dunaway
                                      -------------------------------
                                   Allen R. Dunaway
                                   Chief Financial Officer
                                        3